PRLD
PRLD
NASDAQ · Biotechnology

Prelude Therapeutics Inc

$3.65
+0.23 (+6.73%)
As of Apr 1, 2:56 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +158.1% upside
Low Target $6.99
Average Target $9.42
High Target $10.52
Current Price $3.65
Current
$3.65
Target
$9.42
$6.99 $9.42 avg $10.52
Scenario Analysis
Bear Case
$6.99
91.5%
Low target
Base Case
$9.42
+158.1%
Avg target
Bull Case
$10.52
+188.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.22
-13.5% from high
52-Week Low
$0.61
+498.3% from low
Target vs 52W High
$9.42
+123.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%